All articles tagged with #glaucoma
Scientists report that epigenetic reprogramming to revive youthful cellular memory in aging eye cells has reached humans, with the first patient treated in a Phase 1 trial for glaucoma and other optic neuropathies. The approach could someday restore some lost vision, but safety, delivery, and how durable the effects are remain major hurdles before it becomes a widely available therapy.
A Life Biosciences Phase 1 trial is testing ER-100, a gene therapy designed to reset the aging clock in eye cells using OSK (OCT4, SOX2, KLF4) to potentially restore vision in open-angle glaucoma. Early preclinical data suggest epigenetic restoration can improve cellular function, but the approach carries safety risks, including cancer, and it remains uncertain whether translating this to humans will succeed or be safe.
Scientists have begun the first human trial of partial cellular reprogramming to nudge aging eye cells toward a younger state in hopes of regenerating optic nerve neurons to treat glaucoma. The study by Life Biosciences treated the first participant and plans to enroll up to 12 total; this is an early, experimental approach—not a lifespans therapy—with cancer risk as a key concern and no results yet.
Scientists have treated the first participant in an early-stage clinical trial testing partial cellular reprogramming to make aging cells act younger, aiming to regenerate optic nerve neurons in glaucoma. While promising, the approach is experimental, enrolling up to 12 participants, with potential cancer risk, and is not a universal anti-aging therapy.
As people age, four common eye conditions—diabetic retinopathy, glaucoma, cataracts, and macular degeneration—rise in risk, but most vision loss can be prevented or delayed through regular eye exams (starting after age 45 or when diabetes is diagnosed), a healthy lifestyle, controlling blood pressure, diabetes, and cholesterol, protecting eyes from UV light, and timely treatments such as cataract surgery or glaucoma management; support and rehabilitation options are available for those with visual impairment.
Life Biosciences dosed the first patient in a small, safety-focused trial of ER-100, a gene therapy designed to reset epigenetic marks in retinal ganglion cells to reverse aging-like changes and potentially restore vision in open-angle glaucoma or NAION. Delivered by a virus and activated by a specific antibiotic, the study will enroll up to 18 participants and follow them for years, attracting both optimism about aging biology and warnings about safety risks and uncertain efficacy.
The first participant has been treated in a landmark trial testing partial cellular reprogramming—activating three genes to make aged cells behave younger—in hopes of regenerating optic nerve neurons and treating glaucoma; safety is the primary focus, with low—but not zero—risk of cancer, and results will determine viability for broader use.
Eye exams can uncover serious health problems beyond vision—retinal changes can reveal high blood pressure, glaucoma risk, and diabetic eye disease; doctors can also spot Demodex blepharitis and, if papilledema is present, possible brain tumors or masses, as well as inflammation signaling autoimmune disease. The piece stresses regular annual eye checkups and appropriate follow-ups, with treatments ranging from blood pressure and glucose control to specialized eyelid mite therapy and autoimmune workups as needed.
A study of 144 glaucoma patients found that elevating the head with pillows raises intraocular pressure (IOP) and lowers ocular perfusion pressure (OPP) for many participants, suggesting neck position and jugular vein compression may affect eye drainage; sleeping flat or without a pillow could be a simple adjunct strategy to manage postural IOP, but the study is observational and not proof of causation; results varied by age and glaucoma type, requiring more research.
Some serious health conditions like high blood pressure, sleep apnea, glaucoma, diabetes, PCOS, and lung cancer often have minimal or no symptoms, making regular screenings crucial for early detection and prevention of serious damage.
Diabetes can cause serious eye problems including diabetic retinopathy, macular edema, cataracts, glaucoma, and retinal detachment, which can lead to permanent vision loss if untreated. Managing blood sugar levels and regular eye exams are crucial for prevention and early detection.
Squirrel, a Labradoodle from Perth, Scotland, who loves ambushing her owners and fellow canine friends, has won Pet of the Week. Other finalists include Max, a shelter dog with anxiety and PTSD, London and Sunny, rescue dogs who are inseparable, and Ollie the cat, who needs eye surgery for glaucoma. Owners can submit their pet's photos and stories to be featured in the Pet of the Week lineup.
Research shows that air pollution can harm eyes, leading to vision disorders such as cataracts and glaucoma. Even lower doses of air pollution can have negative effects on eye health, with fine particles from pollution significantly increasing the risk of these diseases. Studies have found that exposure to PM2.5 pollution may lead to accelerated thinning of nerves related to glaucoma, and high levels of pollution have been linked to a higher risk of needing cataract surgery. Pollution-sapping greenery in neighborhoods has been associated with a lower risk of myopia among children, and experts suggest wearing sunglasses, using eyedrops, and eating an antioxidant-rich diet to counteract the damaging effects of air pollution on the eyes. The best way to protect vision from dirty air is to stop burning fossil fuels.
Cataracts and glaucoma are common eye problems that become more prevalent with age, but they differ in their causes and symptoms. Cataracts, a natural part of aging, cause cloudy vision and trouble seeing at night, while glaucoma, a less common eye disease, can lead to a loss of peripheral vision and potential blindness. Risk factors for cataracts include age, sun exposure, smoking, and high blood sugar, while glaucoma risk factors include high eye pressure, uncontrolled high blood sugar, and high blood pressure. Annual eye exams, wearing sunglasses, eating a diet rich in fruits and vegetables, staying physically active, and managing stress are recommended to maintain good eye health and catch any issues early. If experiencing vision changes or eye pain, it's important to seek medical attention from an eye doctor.
Researchers have discovered a molecular switch that regulates the reactivity of astrocytes, a type of brain cell, which can have neurotoxic or neuroprotective effects on the central nervous system. The study found that injured white matter astrocytes can differentiate into two distinct reactive populations, with neuroprotective astrocytes inhibiting microglial activation and promoting cell survival. By targeting this molecular switch, it may be possible to develop new treatments for conditions such as glaucoma and optic neuropathies.